As of June 30, 2026, Galenica AG carries a market capitalization of 4.23B, placing it among publicly traded companies globally. Its enterprise value stands at 4.42B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 4.23B |
| Enterprise Value | 4.42B |
Galenica AG's next confirmed earnings release is scheduled for March 9, 2027.
| Earnings Date | 3/9/2027 |
As of June 30, 2026, Galenica AG has 49.82M shares outstanding.
| Shares Outstanding | 49.82M |
These figures are as of June 30, 2026.
| PB Ratio | 3.00 |
| P/TBV Ratio | -236.70 |
As of June 30, 2026, Galenica AG maintains a current ratio of 1.07, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.07 |
| Quick Ratio | 0.04 |
| Debt / Equity | 16.23 |
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 6,558.00 |
As of the close on October 23, 2026, Galenica AG's stock has declined approximately 3.70% over the past 52 weeks. The 50-day moving average sits at 83.96, while the 200-day moving average is 89.15.
| 52-Week Price Change | -3.70% |
| 50-Day Moving Average | 83.96 |
| 200-Day Moving Average | 89.15 |
As of June 30, 2026, Galenica AG holds 39.61M in cash and equivalents against 229.61M in total debt, resulting in a net debt position of -39.60M. Total book value stands at 1.41B, with working capital of 72.52M providing operational flexibility.
| Cash & Cash Equivalents | 39.61M |
| Total Debt | 229.61M |
| Net Debt | -39.60M |
| Equity (Book Value) | 1.41B |
| Book Value Per Share | 28.34 |
| Working Capital | 72.52M |
Already premium?